| Tanggal | Nama | Perubahan | Sebelum | Sesudah | Harga | Status |
|---|---|---|---|---|---|---|
| 21 Agu 2026 | FERDINAND ARYANTO
Individu · Lokal, Indonesia |
▲
50.000
|
0,00%
360.000 |
0,00%
410.000 |
810 | Bertambah |
| 9 Jul 2026 | RONNY HADIANA
Individu · Lokal, Indonesia |
▲
1.000
|
0,20%
93.571.007 |
0,20%
93.572.007 |
720 | Bertambah |
| 29 Apr 2026 | MULIALIE
Individu · Lokal, Indonesia |
▲
114.940
|
0,00%
250.045 |
0,00%
364.985 |
876 | Bertambah |
| 29 Apr 2026 | JOS IWAN ATMADJAJA
Individu · Lokal, Indonesia |
▲
114.940
|
0,00%
0 |
0,00%
114.940 |
876 | Baru |
| 29 Apr 2026 | KARTIKA SETIABUDY
Individu · Lokal, Indonesia |
▲
114.940
|
0,00%
0 |
0,00%
114.940 |
876 | Baru |
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
| Nama | Domisili | % |
|---|---|---|
|
PT Bintang Toedjoe
Pharmaceutical
|
Jakarta | 100,00% |
|
PT Hexpharm Jaya Laboratories
Pharmaceutical
|
Jakarta | 100,00% |
|
PT Saka Farma Laboratories
Pharmaceutical
|
Jakarta | 100,00% |
|
PT Finusolprima Farma Int.
Pharmaceutical
|
Jakarta | 100,00% |
|
PT Bifarma Adiluhung
Health screening service
|
Jakarta | 100,00% |
|
Innogene Kalbiotech Pte. Ltd.
Agent and representative for biotechnology products
|
Singapore | 93,34% |
|
PT Dankos Farma
Pharmaceutical
|
Jakarta | 100,00% |
|
PT Pharma Metric Labs.
Quality Control Certification Service and Clinical Trial for Pharmaceutical and Consumer Health Products
|
Jakarta | 81,64% |
|
PT KalGen DNA
Screening Service, Supporting Diagnostic Test and Reagen Production
|
Jakarta | 60,00% |
|
PT Kalbio Global Medika
Manufacturing of Biologic Products
|
Jakarta | 100,00% |
|
PT Kalbe Genexine Biologics
Pharmaceutical
|
Jakarta | 60,00% |
|
PT Innolab Sains Internasional
Health Screening Service
|
Jakarta | 60,00% |
|
PT global Onkolab Farma
Pharmaceutical
|
Jakarta | 100,00% |
|
PT Kalbe Myanmar Company Ltd.
Pharmaceutical
|
Myanmar | 100,00% |
|
PT Sanghiang Perkasa
Health Foods
|
Jakarta | 100,00% |
|
PT Kalbe Morinaga Indonesia
Health Foods
|
Jakarta | 70,00% |
|
PT Hale International
Health Drinks
|
Bogor | 100,00% |
|
PT Kalbe Milko Indonesia
Health Foods
|
Bogor | 51,00% |
|
PT Global Vita Nutritech
Premix Industry
|
Jakarta | 100,00% |
|
PT Enseval Putera Megatrading Tbk
Distribution of Pharmaceutical Products, Consumer Products, Medical Equipment, Cosmetics and Other Trading Products
|
Jakarta | 91,80% |
|
PT Tri Sapta Jaya
Distribution of Pharmaceutical Products, Consumer Products, Medical Equipment, Cosmetics and Other Trading Products
|
Jakarta | 91,80% |
|
PT Millenia Dharma Insani
Health Care Clinics
|
Jakarta | 91,80% |
|
PT Enseval Medika Prima
Trading of Medical and Laboratory Equipment and Supplies
|
Jakarta | 91,80% |
|
PT Global Chemindo Megatrading
Trading of Raw Materials for Pharmaceutical Products
|
Jakarta | 91,80% |
|
PT Global Karsa Medika
Wholesale trading of pharmaceutical, medical equipment, foods and drinks
|
Jakarta | 91,80% |
|
PT Renalmed Tiara Utama
Trading of Consumable Products for Hemodialysis Therapy
|
Jakarta | 90,65% |
|
Kalbe Vision Pte. Ltd
Development, Production, Marketing and Distribution of Opthalmic Products
|
Singapore | 100,00% |
|
Kalbe International Pte.Ltd.
Wholesale of Pharmaceutical, Consumer Health and Nutrition Products
|
Singapore | 100,00% |
|
Asiawide Kalbe Philippines, Inc.
Marketing and Distribution of Energy Drinks in a Ready-to-Drink Format
|
Philippines | 50,00% |
|
PT Karsa Lintas Buwana
Advertising
|
Jakarta | 100,00% |
|
Kalbe Malaysia Sdn. Bhd.
Wholesale of Pharmaceutical and Medical Products
|
Malaysia | 100,00% |
|
PT Medika Renal Citraprima
Hemodialysis Clinic, Trading of Consumable Products for Hemodialysis Therapy
|
Jakarta | 91,80% |
|
PT Medika Komunika Teknologi
E-commerce, web portal and online media services
|
Jakarta | 50,00% |
|
PT Cakra Radha Mustika
Digital marketing services
|
Jakarta | 100,00% |
|
PT Karya Hasta Dinamika
Home delivery service
|
Jakarta | 100,00% |
|
Kalbe Global Pte. Ltd
Holding company
|
Singapore | 100,00% |
| Periode | Sales | Net Income | EPS | ROE | ROA | DER | Total Assets | Book Value |
|---|---|---|---|---|---|---|---|---|
| 2026 Q2 | 19,48 T | 1,92 T | 82 | 15,78% | 11,61% | 0,30x | 33,08 T | 519,70 |
| 2026 Q1 | 9,68 T | 1,03 T | 87,92 | 16,94% | 12,87% | 0,26x | 31,99 T | 519,02 |
| 2025 Q4 | 35,32 T | 3,66 T | 78,29 | 15,72% | 11,94% | 0,26x | 30,70 T | 497,99 |
| 2025 Q3 | 25,99 T | 2,63 T | 74,95 | 15,27% | 11,66% | 0,23x | 30,10 T | 490,80 |
| 2025 Q2 | 17,08 T | 1,97 T | 84,26 | 17,64% | 13,39% | 0,24x | 29,51 T | 477,79 |
| 2025 Q1 | 8,85 T | 1,08 T | 91,88 | 18,31% | 14,09% | 0,22x | 30,58 T | 501,69 |
| Kategori | Domestik | Asing |
|---|---|---|
| Korporasi | 30.547.044.910 65,35% | 514.956.718 1,10% |
| Individu | 2.828.083.829 6,05% | 51.630.630 0,11% |
| Asuransi | 2.910.219.900 6,23% | 149.977.818 0,32% |
| Reksa Dana | 1.818.784.501 3,89% | 3.403.511.748 7,28% |
| Dana Pensiun | 481.043.295 1,03% | 860.900.794 1,84% |
| Perusahaan Efek | 54.669.637 0,12% | 530.530.942 1,14% |
| Yayasan | 75.394.030 0,16% | 0 |
| Institusi Keuangan / Bank | 10.466.000 0,02% | 1.144.301.945 2,45% |
| Lainnya | 20.243.100 0,04% | 1.339.146.203 2,87% |
| Total | 38.745.949.202 82,90% | 7.994.956.798 17,10% |
| Tanggal | Jenis | Harga |
|---|---|---|
| 30 Jul 1991 | IPO @ Rp. 7,800 | 1 |
| 30 Okt 1992 | 1:1 Bonus Issue | 1 |
| 30 Apr 1993 | 8:100 Rights @ Rp. 8,530 | 1 |
| 16 Jun 1994 | 3:10 Stock Div. | 1 |
| 30 Jun 1994 | 7;10 Bonus Issue | 1 |
| 2 Okt 1996 | Stock Split | 500 |
| 24 Sep 1999 | Stock Split | 100 |
| 6 Des 2000 | Bonus Issue | 100 |
| 2 Jan 2004 | Stock Split | 50 |
| 21 Des 2005 | Conversion PT. Enseval | 50 |
| 21 Des 2005 | Conversion DNKS (PT. Dankos) | 50 |
| 8 Okt 2012 | Stock Split 1 : 5 | 10 |
| 13 Des 2013 | Decrease in Issued and Fully Paid Shares | 10 |
All market data is a real-time snapshot, delayed at least 10 minute, except where indicated otherwise. All market data presented in this website have been permitted by the Indonesian Stock Exchange. All market data and analysis information provided "as is" for informational purposes only, not intended for trading purposes or advice. IQ Plus is not liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the IQPLUS.info site, you agree not to redistribute the information found therein. All quotes are in West Indonesia Standard Time (WIB).
Komplek Gading Bukit Indah, Blok H24,
Kelapa Gading, Jakarta Utara 14240
Phone : 021-4513821
Email : marketing@iqplus.info
